Orphapacket:
  ORPHApacketId: '401920'
  creationDate: '2020-06-27 22:10:58'
  version: 1.3.6 / 4.1.7 [2020-04-17] (orientdb version)
  copyright: Orphanet (c) 2020
  ORPHAcode: '401920'
  Label: Fibrolamellar hepatocellular carcinoma
  PURL: http://www.orpha.net/ORDO/Orphanet_401920
  DisorderType:
    value: Disease
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
  Synonyms:
  - Synonym: FHCC
  - Synonym: Fibrolamellar hepatocarcinoma
  TextSection:
    TextSectionType: Definition
    Contents: A rare variant of hepatocellular carcinoma (HCC) presenting in adolescents
      or young adults with no underlying liver disease. Clinical presentation is non
      specific with abdominal mass abdominal discomfort or pain fatigue and weight
      loss. Patients can also be asymptomatic. HCC markers (alpha fetoprotein) are
      normal. Fibrolamellar HCC presents as a unique well-delimited mass at imagery
      and a biopsy confirms the diagnosis showing well-differentiated tumor cells
      surrounded by thick collagen bands.
  Genes:
  - Gene:
      Symbol: DNAJB1
      Name: DnaJ heat shock protein family (Hsp40) member B1
      ExternalReferences:
      - Source: HGNC
        Reference: '5270'
      - Source: OMIM
        Reference: '604572'
  - Gene:
      Symbol: PRKACA
      Name: protein kinase cAMP-activated catalytic subunit alpha
      ExternalReferences:
      - Source: HGNC
        Reference: '9380'
      - Source: OMIM
        Reference: '601639'
  Parents:
  - Parent:
    - ORPHAcode: '424936'
      Label: Carcinoma of liver and intrahepatic biliary tract
  Prevalences:
  - Prevalence:
      Source: SEER Surveillance Epidemiology and end results [REG]_14999699[PMID]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: United States
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Austria
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Belgium
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Bulgaria
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Czech Republic
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Estonia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Finland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: France
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Germany
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Iceland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Ireland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Italy
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Latvia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Norway
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Poland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Portugal
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Slovakia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Spain
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Switzerland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Netherlands
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: United Kingdom
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: <1 / 1 000 000
      ValMoy: no data
      PrevalenceGeographic: Europe
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Adolescent
  - AverageAgeOfOnset:
      value: Adult
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Not applicable
